Marey Shriver

Title: Marey Shriver: Innovator in Cancer Prognosis and Therapy

Introduction

Marey Shriver is a notable inventor based in Nottingham, MD (US). He has made significant contributions to the field of cancer research, particularly through his innovative patent related to giant obscurins. His work focuses on improving cancer prognosis and therapy, which has the potential to impact many lives.

Latest Patents

Marey Shriver holds a patent titled "Giant obscurins and uses thereof in cancer prognosis and therapy." This patent provides methods and kits for evaluating the potential for invasiveness, metastasis, or recurrence of epithelial cell cancers. The methods involve detecting the expression profile of giant obscurins in tissue samples of tumor cells. The assessment of giant obscuring expression levels and distribution can indicate the potential for cancer progression. The kit includes a detection reagent suitable for identifying giant obscurins and instructions for its use.

Career Highlights

Throughout his career, Marey Shriver has worked with esteemed institutions such as the University System of Maryland and Johns Hopkins University. His research has focused on the critical intersection of cancer biology and therapeutic development. His innovative approaches have garnered attention in the scientific community.

Collaborations

Marey Shriver has collaborated with notable colleagues, including Konstantinos Konstantopoulos and Aikaterini Kontrogianni-Konstantopoulos. These collaborations have enriched his research and contributed to advancements in cancer prognosis and therapy.

Conclusion

Marey Shriver's contributions to cancer research through his patent on giant obscurins highlight his innovative spirit and dedication to improving patient outcomes. His work exemplifies the importance of research in the fight against cancer.